A
A Zurlo
Researcher at European Organisation for Research and Treatment of Cancer
Publications - 12
Citations - 2078
A Zurlo is an academic researcher from European Organisation for Research and Treatment of Cancer. The author has contributed to research in topics: European union & Prostate cancer. The author has an hindex of 7, co-authored 10 publications receiving 2002 citations.
Papers
More filters
Journal ArticleDOI
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial.
Michel Bolla,Laurence Collette,Leo E.C.M. Blank,Padraig Warde,Jean Bernard Dubois,René-Olivier Mirimanoff,Guy Storme,Jacques Bernier,Abraham Kuten,Cora N. Sternberg,J Mattelaer,José Lopez Torecilla,J Rafael Pfeffer,Carmel Lino Cutajar,A Zurlo,Marianne Pierart +15 more
TL;DR: Immediate androgen suppression with an LHRH analogue given during and for 3 years after external irradiation improves disease-free and overall survival of patients with locally advanced prostate cancer.
Journal ArticleDOI
Phase III Trial of Satraplatin, an Oral Platinum plus Prednisone vs. Prednisone alone in Patients with Hormone-Refractory Prostate Cancer
Cora N. Sternberg,Peter Whelan,J. W. Hetherington,B. Paluchowska,P.H.Th.J. Slee,K. Vekemans,P. van Erps,Christine Theodore,O. Koriakine,T. Oliver,D. Lebwohl,M. Debois,A Zurlo,L. Collette +13 more
TL;DR: This randomized comparison of a combination of satraplatin and prednisone versusprednisone alone supports the antitumor activity of the combination.
Journal ArticleDOI
The EORTC Boron Neutron Capture Therapy (BNCT) Group: achievements and future projects
W Sauerwein,A Zurlo +1 more
TL;DR: The first European clinical trial of BNCT for glioblastoma patients is started at the European High Flux Reactor in Petten, The Netherlands, conducted by the Department of Radiotherapy of the University of Essen, Germany.
Journal ArticleDOI
Late toxicity following conventional radiotherapy for prostate cancer: analysis of the EORTC trial 22863
Fatma Ataman,A Zurlo,X. Artignan,Geertjan van Tienhoven,Leo E.C.M. Blank,Padraig Warde,Jean Bernard Dubois,W. Jeanneret,Frans Keuppens,Jacques Bernier,Abraham Kuten,Laurence Collette,Marianne Pierart,Michel Bolla +13 more
TL;DR: Late toxicity and other serious adverse events (SAE) were analysed in the EORTC trial 22863, which evaluated the value of adjuvant endocrine treatment for locally advanced prostate cancer treated with radiotherapy.
Journal ArticleDOI
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
M. Bolla,L. Collette,Leo E.C.M. Blank,Padraig Warde,J.B Dubois,R.O. Mirimanoff,Guy Storme,Jacques Bernier,Abraham Kuten,Cora N. Sternberg,J Mattelaer,J Lopez Torecilla,J.R Pfeffer,C Lino Cutajar,A Zurlo,Marianne Pierart,Mark A. Ritter +16 more